Industry News
What Is Piroctone Olamine, Can It Get Rid…
Piroctone Olamine is an effective ingredient for controlling dandruff and promoting a healthy scalp.
TROP-2 directed antibody-drug conjugates …
Trop2 has gained significant attention in antibody-drug conjugate (ADC) research as a potential therapeutic target due to its widespread expression in tumor tissues and limited expression in …
Summary of ADC Targets for Breast Cancer
Some new ADC antigen targets for breast cancer, including Nectin-4, HER3, tissue factor (TF), FRα, LIV-1, ROR1-2, and B7-H4, etc.
Pro-xylane – Powerful Cosmetic Ingredien…
Pro-xylane, also known as hydroxyethyl tetrahydropyrantriol, is an anti-aging active substance that promotes the synthesis of collagen.
Advances in Nonalcoholic Fatty Liver Dise…
The U.S. FDA has not yet approved any drugs for NASH treatment. The search for an effective and safe treatment for NASH is urgent.
Molecular glues: Current Satus and Future…
What are molecular glues? What are advantages of molecular glues over PROTACs? And list of molecular glues approvals and in clinic trails.
Summary of GLP-1 Drug Long-Acting Strateg…
To address the issue of a short half-life, various methods and strategies have been employed from two perspectives: enhancing tolerance to DPP-4 enzyme and reducing in vivo clearance.
Summary of ADCs in Clinical Phase 3
Summary of FDA approved ADCs and ADCs in clinical phase 3.
Classification of Anticoagulant Drugs
4 types of anticoagulants: Vitamin K antagonists (VKA), indirect thrombin inhibitors, direct thrombin inhibitors and factor Xa inhibitors. and Representative Drugs
Semaglutide Indication Opportunity: From …
On October 10, 2023, Novo Nordisk announced the early termination of a Phase 3 clinical trial of semaglutide for the treatment of patients with kidney injury and chronic kidney disease who ha…